Cardiometabolic Health Congress

JUNE 27, 2024

Competence in selecting treatments for long-term obesity management rose from 43% pre-test to 95% post-test. Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress , Informa Connect, recently presented significant findings at the 84th American Diabetes Association (ADA) Scientific Sessions.

CME 59

CME Diabetes Obesity Education 59

Cardiometabolic Health Congress

JUNE 24, 2024

As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.

Patient Care 52

Patient Care Obesity Education CME 52

Cardiometabolic Health Congress

JULY 12, 2023

A vast collection of webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and many other resources are now grouped into areas of specialty focus. For instance, a pediatric provider may be only interested in topics pertaining to childhood obesity.

Education 52

Education Webinar CME Pediatrics 52

Cardiometabolic Health Congress

FEBRUARY 23, 2024

Black History Month is a poignant backdrop to the alarming rise in obesity and type 2 diabetes, particularly among those of marginalized populations. This troubling trend has cemented the 100-year reign of cardiovascular diseases (CVD) as the #1 killer in America.

Risk Factors 105

Risk Factors Health Disparities Education CME 105

Cardiometabolic Health Congress

JULY 25, 2024

Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 98

Education Innovation Risk Factors Obesity 98

Cardiometabolic Health Congress

AUGUST 14, 2024

Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. CME-Supported Satellites and Sessions: Primetime CME Symposium Integrated Approach to Cardiorenal Management: Maximizing SGLT2 Inhibitor Benefits and Early Detection of HF and CKD Supported by an educational grant from BI-Lilly. Chair: Erin D.

CME 72

CME Education Diabetes Innovation 72